Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.
Combes A, Saura O, Nesseler N, Lebbah S, Rozec B, Levy B, Fellahi JL, Beurton A, Meslin S, Gaudard P, Bouglé A, Vincentelli A, Sonneville R, Lebreton G, Lévy D, Ouattara A, Tubach F; LEVOECMO Trial Group and the International ECMO Network (ECMONet).
Combes A, et al.
JAMA. 2026 Jan 6;335(1):60-69. doi: 10.1001/jama.2025.19843.
JAMA. 2026.
PMID: 41324946
Clinical Trial.